GEN - Genetic Engineering and Biotechnology News29 分钟
New Target for Lyme Disease Vaccine Shows Promise in Preclinical Models
Researchers have engineered Lyme bacterial protein, CspZ, to produce a robust immune response in mice for vaccine development.